Skip to content

A Study on the Clinical Efficacy and Neurobiological Mechanisms of Transcranial Temporal Interference Stimulation (tTIS) in Improving Cognitive Control Function in Schizophrenia Patients

A Study on the Clinical Efficacy and Neurobiological Mechanisms of Transcranial Temporal Interference Stimulation (tTIS) in Improving Cognitive Control Function in Schizophrenia Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118516
Enrollment
Unknown
Registered
2026-02-06
Start date
2026-02-24
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia with cognitive impairment

Interventions

Active ?-tTIS group:Active ?-tTIS
Sham ?-tTIS group:Sham ?-tTIS

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for schizophrenia according to the DSM-5; 2. Aged 18-60 years; 3. A total PANSS score of >=60, with a score of >=10 on the Positive Scale and a score of >=7 on the Negative Scale. 4. Willing to participate and sign the informed consent. 5. No clinically significant abnormalities or stable and controllable conditions in physical examination, medical history, vital signs, routine blood and urine tests, liver and kidney function, electrolytes, electrocardiogram (ECG), electroencephalogram (EEG), or other indicators; 6. Antipsychotic medication regimen stable for at least 4 weeks and dose stable for at least 2 weeks;

Exclusion criteria

Exclusion criteria: 1. Severe agitation or self/other harm risk. 2. Intracranial metal implants, history of epilepsy/seizure induction, pacemakers, or other contraindications for electrical stimulation; 3. Received electroconvulsive therapy in the past month; 4. Pregnancy or breastfeeding; 5. History of alcohol or other substance abuse, or severe physical illness; 6. Visual impairment that prevents completion of cognitive behavioral tasks;

Design outcomes

Primary

MeasureTime frame
Cognitive-behavioral task indices, such as accuracy and reaction time;

Secondary

MeasureTime frame
Scores of the Adverse Event Record Form;cognitive function and clinical symptoms;Neurophysiological indicators drived from eletropgysiology and neuroimaging;

Countries

China

Contacts

Public ContactWang Yucheng

Affiliated Kangning Hospital of Ningbo University

462605905@qq.com+86 574 2630 2529

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026